Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide

Treatment for Primary CNS Lymphoma: The Next Step

2000 • 604 citations

Rituximab Dose-Escalation Trial in Chronic Lymphocytic Leukemia

2001 • 603 citations

Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment

2002 • 404 citations

Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules

2003 • 365 citations

Results of Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue in 22 Patients With Refractory or Recurrent Primary CNS Lymphoma or Intraocular Lymphoma

2001 • 307 citations

Chemotherapy Alone as Initial Treatment for Primary CNS Lymphoma in Patients Older Than 60 Years: A Multicenter Phase II Study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group

2003 • 254 citations

Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: response to therapy and quality of life of patients.

1999 • 161 citations

One week on/one week off: A novel active regimen of temozolomide for recurrent glioblastoma

2004 • 157 citations

Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas

2004 • 119 citations

Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial

2004 • 116 citations

PCV salvage chemotherapy for recurrent primary CNS lymphoma

2000 • 104 citations

Salvage treatment with etoposide (VP‐16), ifosfamide and cytarabine (Ara‐C) for patients with recurrent primary central nervous system lymphoma

2003 • 102 citations

Treatment of CNS Lymphoma with the Anti-CD20 Antibody Rituximab: Experience with Two Cases and Review of the Literature

2003 • 58 citations